S100A7 and breast carcinoma: In recent years, a number of studies demonstrated that the dysregulation of S100A7 was a common feature in various cancer cells, especially in breast cancer,29 oral squamous cell carcinoma,17, 30 gastric cancer,31 and lung cancer.32, 33